FDA denies petitions on synthetic peptides

The US Food and Drug Administration (FDA) has simultaneously denied citizen petitions filed by Amneal and Novo Nordisk that sought to block respectively approvals for generic and follow-on versions of Eli Lilly’s Forteo (teriparatide) and the Danish originator’s liraglutide products containing synthetically derived active substances.